Syndax Pharmaceuticals Inc
SNDX
ISIN null / Valor 24112479
Syndax Pharmaceuticals Inc
UMushroom community rating:
About company
Syndax Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for cancer treatment. The company aims to extend and improve the lives of cancer patients by leveraging cutting-edge scientific research and advancements. Syndax collaborates with various stakeholders in the medical and scientific communities to identify and develop promising drug candidates. The company's pipeline includes treatments designed to address unmet medical needs in oncology, with a particular emphasis on novel mechanisms of action and overlooked aspects of cancer biology. Through these efforts, Syndax seeks to bring new, effective treatment options to market, enhancing patient outcomes and advancing the field of cancer therapy.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
1933 M
Market cap (USD)
2,197,366
Daily traded volume (Shares)
12.75 / 12.4
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Liam Hawkeswood
Liam Hawkeswood
****** Panggabean
EQUITIES OF THE SAME SECTOR
